Over the course of the study, 26% of GLP-1 users stopped taking the medication and about 23% had an interruption of six months or more followed by resuming treatment
Second, use the brand period to demonstrate clinical differentiation extended-release formulations, specific dosing regimens, device combinations that creates genuine reasons for prescribers to prefer the brand over the generic even at a price premium, not just patented reasons
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial
Lets dive into the science behind GLP-1 and explore its potential as a tool for achieving and maintaining a healthy weight
doi: 10.3390/ijms21051725 [DOI] [PMC free article] [PubMed] [Google Scholar] 32.Ma DL, Chen FQ, Xu WJ, Yue WZ, Yuan G, Yang Y
The store-bought Jello that most people think of is mostly sugar, artificial flavors, and a tiny amount of gelatin